vs
Side-by-side financial comparison of JOINT Corp (JYNT) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
JOINT Corp is the larger business by last-quarter revenue ($15.2M vs $13.2M, roughly 1.1× TriSalus Life Sciences, Inc.). JOINT Corp runs the higher net margin — 6.5% vs -73.9%, a 80.4% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 3.1%). JOINT Corp produced more free cash flow last quarter ($334.7K vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -28.6%).
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
JYNT vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.2M | $13.2M |
| Net Profit | $991.1K | $-9.8M |
| Gross Margin | 81.4% | 86.7% |
| Operating Margin | 4.9% | -24.8% |
| Net Margin | 6.5% | -73.9% |
| Revenue YoY | 3.1% | 59.8% |
| Net Profit YoY | 5510.5% | 3.5% |
| EPS (diluted) | $0.06 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.2M | $13.2M | ||
| Q3 25 | $13.4M | $11.6M | ||
| Q2 25 | $13.3M | $11.2M | ||
| Q1 25 | $13.1M | $9.2M | ||
| Q4 24 | $14.7M | $8.3M | ||
| Q3 24 | $30.2M | $7.3M | ||
| Q2 24 | $30.3M | $7.4M | ||
| Q1 24 | $29.7M | $6.5M |
| Q4 25 | $991.1K | $-9.8M | ||
| Q3 25 | $855.0K | $-10.8M | ||
| Q2 25 | $93.4K | $-8.3M | ||
| Q1 25 | $967.8K | $-10.4M | ||
| Q4 24 | $17.7K | $-10.1M | ||
| Q3 24 | $-3.2M | $-2.4M | ||
| Q2 24 | $-3.6M | $-4.3M | ||
| Q1 24 | $947.0K | $-13.2M |
| Q4 25 | 81.4% | 86.7% | ||
| Q3 25 | 80.1% | 83.5% | ||
| Q2 25 | 79.1% | 83.9% | ||
| Q1 25 | 77.3% | 83.7% | ||
| Q4 24 | 78.4% | 85.3% | ||
| Q3 24 | 90.7% | 86.3% | ||
| Q2 24 | 90.7% | 87.6% | ||
| Q1 24 | 90.9% | 85.0% |
| Q4 25 | 4.9% | -24.8% | ||
| Q3 25 | 1.2% | -77.9% | ||
| Q2 25 | -8.6% | -65.4% | ||
| Q1 25 | -5.2% | -79.9% | ||
| Q4 24 | 5.5% | -91.8% | ||
| Q3 24 | -1.6% | -118.9% | ||
| Q2 24 | -5.9% | -111.0% | ||
| Q1 24 | -1.4% | -180.8% |
| Q4 25 | 6.5% | -73.9% | ||
| Q3 25 | 6.4% | -93.5% | ||
| Q2 25 | 0.7% | -73.9% | ||
| Q1 25 | 7.4% | -113.2% | ||
| Q4 24 | 0.1% | -122.4% | ||
| Q3 24 | -10.5% | -32.6% | ||
| Q2 24 | -11.9% | -58.8% | ||
| Q1 24 | 3.2% | -204.5% |
| Q4 25 | $0.06 | $-0.22 | ||
| Q3 25 | $0.06 | $-0.96 | ||
| Q2 25 | $0.01 | $-0.27 | ||
| Q1 25 | $0.06 | $-0.39 | ||
| Q4 24 | $0.01 | $-0.38 | ||
| Q3 24 | $-0.21 | $-0.12 | ||
| Q2 24 | $-0.24 | $-0.21 | ||
| Q1 24 | $0.06 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.6M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.1M | $-33.9M |
| Total Assets | $61.0M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.6M | $20.4M | ||
| Q3 25 | $29.7M | $22.7M | ||
| Q2 25 | $29.8M | $26.5M | ||
| Q1 25 | $21.9M | $13.0M | ||
| Q4 24 | $25.1M | $8.5M | ||
| Q3 24 | $20.7M | $11.3M | ||
| Q2 24 | $17.5M | $16.5M | ||
| Q1 24 | $18.7M | $4.0M |
| Q4 25 | $15.1M | $-33.9M | ||
| Q3 25 | $22.7M | $-26.7M | ||
| Q2 25 | $23.2M | $-19.4M | ||
| Q1 25 | $22.8M | $-34.4M | ||
| Q4 24 | $20.7M | $-25.9M | ||
| Q3 24 | $20.5M | $-20.4M | ||
| Q2 24 | $23.2M | $-25.3M | ||
| Q1 24 | $26.2M | $-36.0M |
| Q4 25 | $61.0M | $35.3M | ||
| Q3 25 | $69.4M | $36.5M | ||
| Q2 25 | $73.2M | $41.3M | ||
| Q1 25 | $80.1M | $28.6M | ||
| Q4 24 | $83.2M | $24.0M | ||
| Q3 24 | $79.6M | $27.5M | ||
| Q2 24 | $82.4M | $32.4M | ||
| Q1 24 | $85.7M | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-2.5M |
| Free Cash FlowOCF − Capex | $334.7K | $-2.5M |
| FCF MarginFCF / Revenue | 2.2% | -19.1% |
| Capex IntensityCapex / Revenue | 9.9% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.86× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.9M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.8M | $-2.5M | ||
| Q3 25 | $1.8M | $-3.7M | ||
| Q2 25 | $868.6K | $-7.3M | ||
| Q1 25 | $-3.7M | $-4.5M | ||
| Q4 24 | $9.4M | $-5.7M | ||
| Q3 24 | $3.4M | $-10.8M | ||
| Q2 24 | $-973.5K | $-13.4M | ||
| Q1 24 | $2.8M | $-10.9M |
| Q4 25 | $334.7K | $-2.5M | ||
| Q3 25 | $1.5M | $-3.9M | ||
| Q2 25 | $363.6K | $-7.4M | ||
| Q1 25 | $-4.0M | $-5.3M | ||
| Q4 24 | $8.2M | $-5.8M | ||
| Q3 24 | $3.2M | $-11.0M | ||
| Q2 24 | $-1.2M | $-13.5M | ||
| Q1 24 | $2.4M | $-10.9M |
| Q4 25 | 2.2% | -19.1% | ||
| Q3 25 | 10.9% | -33.9% | ||
| Q2 25 | 2.7% | -66.1% | ||
| Q1 25 | -30.8% | -57.3% | ||
| Q4 24 | 55.9% | -69.7% | ||
| Q3 24 | 10.6% | -149.9% | ||
| Q2 24 | -4.1% | -183.1% | ||
| Q1 24 | 8.1% | -169.3% |
| Q4 25 | 9.9% | 0.3% | ||
| Q3 25 | 2.4% | 1.9% | ||
| Q2 25 | 3.8% | 0.8% | ||
| Q1 25 | 2.5% | 8.2% | ||
| Q4 24 | 8.1% | 0.6% | ||
| Q3 24 | 0.8% | 2.3% | ||
| Q2 24 | 0.9% | 0.8% | ||
| Q1 24 | 1.3% | 1.0% |
| Q4 25 | 1.86× | — | ||
| Q3 25 | 2.07× | — | ||
| Q2 25 | 9.30× | — | ||
| Q1 25 | -3.82× | — | ||
| Q4 24 | 532.98× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
TLSI
Segment breakdown not available.
